Practical Tips for Diagnosis and Management of Concomitant Inflammatory Spondyloarthritis and Inflammatory Bowel Disease
- PMID: 40658153
- PMCID: PMC12259774
- DOI: 10.1007/s11894-025-00990-8
Practical Tips for Diagnosis and Management of Concomitant Inflammatory Spondyloarthritis and Inflammatory Bowel Disease
Abstract
Purpose of review: The goal of this review is to provide practical guidance for gastroenterologists regarding diagnosis and management of inflammatory bowel disease associated spondyloarthritis.
Recent findings: While there is limited data regarding optimal management approaches, we summarize available screening tools along with classification and consensus criteria that can be deployed in this setting and offer guidance regarding patient symptoms, physical exam findings, laboratory data, and imaging strategies that may facilitate diagnosis. In addition, we outline various therapeutic options available while highlighting deficits in the currently available literature. Inflammatory bowel disease associated spondyloarthritis is common but remains poorly understood. Ongoing research to establish a clear diagnostic pathway and reproducible treatment targets is essential to better identify and treat this patient population.
Keywords: Axial arthritis; Crohn’s disease; Inflammatory arthritis; Inflammatory bowel disease; Spondyloarthritis; Ulcerative colitis.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethical Approval: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines). Competing Interests: KF receives grant funding from the Crohn’s and Colitis Foundation (916943) and Pfizer (90146787). She served on an advisory panel for Janssen. MF consultant for BD Peripheral Vascular (Tempe, AZ) and Siemens Ultrasound (Issaquah, Washington). SC has no disclosures MEH consultant to Abbvie, BMS, Novartis, Eli Lilly, Janssen, and UCB, co-inventor PASE questionnaire receives royalties. Grant funded from the Arthritis Foundation and National Psoriasis Foundation and NIH. FR is a consultant to Adiso, Adnovate, Agomab, Allergan, AbbVie, Arena, Astra Zeneca, Bausch & Lomb, Boehringer-Ingelheim, Celgene/BMS, Celltrion, CDISC, Celsius, Cowen, Eugit, Ferring, Galapagos, Galmed, Genentech, Gilead, Gossamer, Granite, Guidepoint, Helmsley, Horizon Therapeutics, Image Analysis Limited, Index Pharma, Landos, Jannsen, Koutif, Mestag, Metacrine, Mirum, Mopac, Morphic, Myka Labs, Organovo, Origo, Palisade, Pfizer, Pliant, Prometheus Biosciences, Receptos, RedX, Roche, Samsung, Sanofi, Surmodics, Surrozen, Takeda, Techlab, Teva, Theravance, Thetis, Trix Bio, UCB, Ysios, 89Bio.
Similar articles
-
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2. Cochrane Database Syst Rev. 2021. PMID: 34844288 Free PMC article.
-
Patient education interventions for the management of inflammatory bowel disease.Cochrane Database Syst Rev. 2023 May 4;5(5):CD013854. doi: 10.1002/14651858.CD013854.pub2. Cochrane Database Syst Rev. 2023. PMID: 37172140 Free PMC article.
-
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.Cochrane Database Syst Rev. 2006 Apr 19;(2):CD000279. doi: 10.1002/14651858.CD000279.pub3. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2017 Sep 18;9:CD000279. doi: 10.1002/14651858.CD000279.pub4. PMID: 16625534 Updated.
-
Systemic Inflammatory Response Syndrome.2025 Jun 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jun 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31613449 Free Books & Documents.
-
AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.Clin Gastroenterol Hepatol. 2025 Jul;23(8):1291-1302. doi: 10.1016/j.cgh.2025.02.015. Epub 2025 May 19. Clin Gastroenterol Hepatol. 2025. PMID: 40387691 Review.
References
-
- Vavricka SR, Brun L, Ballabeni P, Pittet V, Vavricka BMP, Zeitz J et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106(1). - PubMed
-
- Falloon K, Forney M, Husni ME, Feagan B, Rieder F. Diagnosis and management of inflammatory bowel Disease-Associated spondyloarthritis. Am J Gastroenterol. 2024;120(1). - PubMed
-
- Falloon K, Dossaji Z, Mude P, Bhalla J, Bhattacharya A, Cheemalavagu S, et al. Diagnosis of inflammatory bowel Diseases-Associated peripheral spondyloarthritis: A systematic Reiew. Inflamm Bowel Dis J. 2024;31(3). - PubMed
-
- Yang X, Fan D, Xia Q, Wang M, Zhang X, Li X, et al. The health-related quality of life of ankylosing spondylitis patients assessed by SF-36: a systematic review and meta-analysis. Qual Life Res. 2016;25(11):2711–23. - PubMed
-
- Ghosh S, Casellas F, O’Shea C, Leonard M, Petersson J, Peyrin-Biroulet L. P410 extraintestinal manifestations and quality of life in patients with ulcerative colitis: 1-year data from ICONIC. J Crohns Colitis. 2019;13(Supplement_1).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials